$0.3300
0.014.30%
At close: -
$0.3538
0.027.21%
After Hours: Dec 20, 5:55 PM EDT
Comments
Loading...
Virpax Pharmaceuticals (NASDAQ:VRPX) Stock, Earnings Estimates, EPS, And Revenue
Virpax Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-0.430
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Virpax Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Virpax Pharmaceuticals (VRPX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-14 | $-0.43 | $-0.58 | 25.9 % |
| Dec 2023 | 2024-03-26 | $-3.87 | $-2.70 | -43.3 % |
Virpax Pharmaceuticals (VRPX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Virpax Pharmaceuticals (NASDAQ:VRPX) reporting earnings?
Virpax Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Virpax Pharmaceuticals (NASDAQ:VRPX)?
Virpax Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $-0.43, which beat the estimate of $-0.58.
What were Virpax Pharmaceuticals’s (NASDAQ:VRPX) revenues?
Virpax Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.